Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1400 participants
OBSERVATIONAL
2021-02-25
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HeartStart FRx Defibrillator Event Registry
NCT04250857
Optimisation of Decision Making for Defibrillator Implantation in Hypertrophic Cardiomyopathy
NCT03846297
Prospective Study to Identify Patients at Risk of Dangerous Ventricular Arrhythmias
NCT00562757
Personalized Risk Identification and Management for Arrhythmias and Heart Failure by ECG and MRI
NCT01353131
Use of Defibrillator Information in the Emergency Department
NCT00708058
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Suspected Sudden Cardiac Arrest
All subjects with suspected of a circulatory arrest of any cause.
HeartStart HS1
Automated External Defibrillator
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HeartStart HS1
Automated External Defibrillator
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have had HeartStart HS1 Defibrillator with electrodes:
Adult SMART Pads Cartridge \[REF: M5071A\], Infant/Child SMART Pads Cartridge (REF:M5072A) applied to their body and powered up with HS1 battery (Model M5070A), regardless of whether a defibrillation shock was delivered
Exclusion Criteria
* AED or pad use other than the HeartStart HS1 Defibrillator with above referenced Philips electrode pads. Note: Use of a device other than the Philips HeartStart HS1 AED does not preclude enrollment if the AED or an Advanced Life Support defibrillator was used after the HeartStart HS1 AED.
* AED used for training purposes.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Philips Clinical & Medical Affairs Global
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gerrit Noordergraaf, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Philips Healthcare
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Philips
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TC_ECR_HS1_2020_10819
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.